DHG Pharmaceutical JSC (HOSE:DHG)

Market Cap	12.19T -5.9%
Revenue (ttm)	5.27T +9.3%
Net Income	872.74B +9.6%
EPS	6,675.06 +9.7%
Shares Out	130.75M
PE Ratio	13.96
Forward PE	12.04
Dividend	5,000.00 (5.36%)
Ex-Dividend Date	May 11, 2026

Volume	4,566
Open	93,500
Previous Close	93,200
Day's Range	93,100 - 93,500
52-Week Range	92,300 - 110,000
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 22, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, dermatology, and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceutical...

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 2,806
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DHG

Financial Performance

In 2025, DHG Pharmaceutical JSC's revenue was 5.27 trillion, an increase of 7.82% compared to the previous year's 4.88 trillion. Earnings were 824.78 billion, an increase of 9.45%.